Cancer Immunotherapy Market to Undertake Strapping Growth by the End 2024
Owing to the presence of a pool of small and large players, the global cancer immunotherapy makes for a fragmented competitive landscape, although Roche Holding AG has managed to stay ahead of the curve in the recent past, according to a business intelligence report by Transparency Market Research (TMR). The report, developed as a reliable decision making tool for stockholders such as drug manufacturers and suppliers as well as research and development companies, has attributed the recent approvals of monoclonal...
View full press release